Apple is reportedly waiting for the FDA to approve the iWatch

Apple’s first-generation iWatch is awaiting certification from the US Food and Drug Administration (FDA) before it enters mass production for a launch this Fall, claims Chinese website Laoyaoba. Citing inside sources, the site claims that Apple has already finalized the design and specifications of the watch, noting that the company is trying to get the device certified as medical equipment. It was reported earlier this month that Apple had met with the FDA in December to discuss a number of topics, with some suggesting that Apple might be laying some groundwork for the iWatch. However, a memo issued by the FDA noted that the dialogue merely revolved around its guidance on mobile apps and making sure that the technology industry and regulators are on the same page.

The iWatch has become one of the most anticipated gadgets of the year, and for many months it’s been the source of tons of speculations and rumors. This is to be expected given Apple’s huge influence on the market, especially since the iWatch would be the company’s fist “wearable”. Every week we come across new information regarding Apple’s upcoming smartwatch, and with each new report we’re hoping that the puzzle will become clearer and clearer. Nevertheless, not everything we hear about the iWatch is solely positive, and sometimes we get a mixed bag of both good and bad news. Today we’re in a similar situation, as the latest reports suggest that the iWatch is actually being held back, but for good reasons. Scroll down for the full story below. According to the latest reports coming from the Chinese media (citing “Apple insiders”), iWatch’s development has already been completed (meaning design, technical specs, features, etc). However, the gadget is being held back (aka is not being manufactured yet) because it needs to be certified by the U.S. Food and Drug Administration (FDA).